Trial
NCT02975336
A Phase II Study of M2951 in SLE
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators
Merck KGaA, Darmstadt, Germany
Condition
Systemic Lupus Erythematosus
Intervention
Placebo
Why stopped
Study is completed; primary analysis completed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-12